BHST BioHarvest Sciences Inc: יחס שווי פעילות לרווח לפני ריבית, מסים ופחת

Intellectual property protection and strict regulatory standards create a formidable barrier for competitors attempting to replicate hydroponic synthesis methods. A cohesive team of plant cell biology experts ensures research stability. BioHarvest Sciences (BHST) revenues are based on the sale of bioactive components through the Bio-Plant system. This chart shows a market EV/EBITDA multiple of 0.00, visualizing the business value relative to its operating profit.

BioHarvest Sciences (BHST) is scaling its VINIA platform and expanding into the US nutraceuticals market, which necessitates an assessment of capital intensity. The multiple compares the total enterprise value to operating profit before depreciation and amortization, determining the company's ability to service debt and taxes. An analysis of the company's EV/EBITDA value on this chart reveals stable cash flows during periods of turbulence. The decreasing volatility of this indicator confirms fundamental resilience during the transition to B2B contracts.